LONDON and PHILADELPHIA, June 5 /PRNewswire/ --

Thomson Reuters, the world's leading source of intelligent information
for businesses and professionals, today announced the addition of Prous
Science routes of synthesis (ROS) data to the Newport Horizon Premium and
Newport Vision Premium solutions. An ROS focused search allows users to
identify active pharmaceutical ingredients (APIs) according to an
intermediate or reagent used, number of available routes or by patents
referenced in a given route. Provided free of charge to current subscribers
of the Premium systems, this new dataset, which provides an exciting
compliment to the kilogram demand data released in March, enhances product
targeting, business development and competitive intelligence by helping users
to understand better the chemistry and manufacture of APIs.

The true or original manufacturing process used for a particular API is
usually well protected by patents, making it challenging to devise
equivalent, cheaper or more efficient processes without infringing on the
originator's intellectual property. The new dataset will help to remedy this
by providing extensive information for more than 2,500 APIs, consisting of:

-- Full chemical name
    -- CAS number
    -- Synthesis route diagram
    -- Text commentary (with each step indexed to the diagram)
    -- Patent references (linked to the patent page)
    -- Intermediate chemicals and CAS numbers
    -- Reagent chemicals and CAS numbers
    -- Scientific journal references



"Understanding the 'recipe' of how a particular active ingredient is made
-- or could be made -- is of vital importance to API manufacturers, generic
companies and innovators," said Mike Chace-Ortiz, Senior Director, Product
Strategy, Thomson Reuters. "By providing access to this important data,
Newport Horizon Premium and Newport Vision Premium now allow our customers to
gauge which patents are involved, what raw materials are needed, the cost and
complexity of the process and whether specialized equipment or facilities
must be bought or constructed."

For further information on Thomson Reuters API Intelligence solutions,
visit: http://scientific.thomsonreuters.com/newport/

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information
for businesses and professionals. We combine industry expertise with
innovative technology to deliver critical information to leading decision
makers in the financial, legal, tax and accounting, scientific, healthcare
and media markets, powered by the world's most trusted news organization.
With headquarters in New York and major operations in London and Eagan,
Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries.
For more information, go to www.thomsonreuters.com.

Web site: http://www.thomsonreuters.com
              http://scientific.thomsonreuters.com/newport